We therefore agree with the EASL that NCC-S (when determined by calculation from serum levels of copper and ceruloplasmin) is not recommended for diagnosis of WD (29, 33) and that NCC-S is of little value for therapy monitoring of WD. Here, CP is linked to Wilson disease.